BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Trogarzo (Ibalizumab) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Trogarzo (Ibalizumab)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07635992-964@assetmemo.bio
DTSTAMP:20261121T005645Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Trogarzo (Ibalizumab): Phase 1 readout est. (NCT07635992)
DESCRIPTION:Trogarzo (Ibalizumab)\, phase 1\, HIV.\nStudy: A Clinical Study
  Evaluating the Safety\, Tolerability\, and Effect on HIV Reservoir of Iba
 lizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in Peopl
 e Living With HIV\nEstimated primary completion: 31 December 2028. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/ibalizumab#upcoming-events\n
 Registry record: https://clinicaltrials.gov/study/NCT07635992
URL:https://assetmemo.bio/drug/ibalizumab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
